Weekend Roundup: Can an ‘Elderly and Haggard’ Europe Defend a ‘World of Rules’ Against Russia?

As Pope Francis slammed Europe as “elderly and haggard” in an address this week in Strasbourg, the speaker of the Polish parliament, Radek Sikorski, warned in the WorldPost that Europe’s starkest challenge is defending “a world of rules” against an aggressive Russia. Writing from the Vatican for our “Following Francis” series, Sébastien Maillard looks at the “holy ghostwriters” behind the pontiff’s tweets and encyclicals.

WorldPost Middle East Correspondent Sophia Jones reports from Istanbul on yet another retrograde move in Turkey’s modern history taken by President Recep Tayyip Erdogan, who declared this week that men and women can’t be equal. Though Erdogan still considers the Kurdish Democratic Union Party a terrorist organization, Nazand Begikhani writes from Iraqi Kurdistan about how women from that party who have taken up arms to defend their fellow Kurds from the radically misogynist Islamic State are also advancing equal rights in their own society.

This week, as the Israeli cabinet moved to define Israel as a “Jewish state,” the French parliament, like other European parliaments of late, is voting on whether to recognize a Palestinian state. Writing from Paris, —> Read More Here

The Regeneration Generation: A Conversation With Bob Hariri, Vice-Chairman and Co-Founder of Human Longevity Inc.

Bob Hariri, M.D., Ph.D., is the vice chairman of Human Longevity Inc. (HLI), a genomics and cell-therapy diagnostics and therapeutics company he co-founded in 2013 with Craig Venter and Peter Diamandis, which is focused on extending the healthy, high-performance human lifespan. Utilizing technological advancements in genomics, bioinformatics, computing and cell therapy, HLI plans to develop therapeutic solutions to some of the most complex yet actionable diseases, such as cancer, heart disease and dementia. A recipient of the Thomas Alva Edison Award in 2007 and 2011, the former CEO of Celgene Cellular Therapeutics, and one of the pioneers of the global cell-therapy industry, Bob recently sat down with me to discuss his current work on the frontiers of aging and cellular science.

You’ve formed one of the most provocative and promising companies working in the cellular sciences. How did you get together with Craig Venter and Peter Diamandis of the X PRIZE?

I am very fortunate to have two remarkable visionary friends in Craig and Peter. I have admired the work that Craig has done in the broad landscape of genomics and synthetic biology and have always been inspired by his pioneering approach as an entrepreneur. —> Read More Here

1 2 3 710